Urinary 6-Sulphatoxymelatonin Excretion of Rats is not Changed by 24 Hours of Exposure to A Horizontal 50-HZ, 100-μT Magnetic Field

References

• Feychting M., Schulgen G., Olsen J. H., Ahlbom A. Magnetic fields and childhood cancer—a pooled analysis of two Scandinavian studies. Eur. J. Cancer 1995; 31A: 2035–2039
   PubMed Web of Science ®Google Scholar
• Wertheimer N., Leeper E. Electrical wiring configurations and childhood cancer. Am. J. Epidemiol. 1979; 109: 273–284
   PubMed Web of Science ®Google Scholar
• Stevens R. G., Davis S. The melatonin hypothesis: electric power and breast cancer. Environ. Health. Perspect. 1996; 104(suppl. 1)135–140
   PubMedGoogle Scholar
• Gurney J. G., Mueller B. A., Davis S., Schwartz S. M., Stevens R. G., Lopecky K. J. Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use. Am. J. Epidemiol. 1996; 143: 120–128
   PubMed Web of Science ®Google Scholar
• Mevissen M., Lerchl A., Löscher W. Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field. J. Toxicol. Environ. Health 1996; 48: 169–185
   PubMed Web of Science ®Google Scholar
• Mevissen M., Lerchl A., Szamel M., Löscher W. Exposure of DMBA-treated female rats in a 50 Hz, 50μTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation. Carcinogenesis 1996; 17: 903–910
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Melatonin: that ubiquitously acting pineal hormone. News Physiol. Sci. 1991; 6: 223–227
   Google Scholar
• Deacon S., Arendt J. Adapting to phase shifts, I. An experimental model for jet lag and shift work. Physiol. Behav. 1996; 59: 665–673
   PubMed Web of Science ®Google Scholar
• Deacon S., Arendt J. Adapting to phase shifts, II. Effects of melatonin and conflicting light treatment. Physiol. Behav. 1996; 59: 675–682
   PubMed Web of Science ®Google Scholar
• Skene D. J., Deacon S., Arendt J. Use of melatonin in circadian rhythm disorders and following phase shifts. Acta Neurobiol. Exp. 1996; 56: 359–362
   PubMed Web of Science ®Google Scholar
• Bergiannaki J. D., Paparrigopoulos T. J., Stefanis C. N. Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations. Experientia 1996; 52: 253–258
   PubMedGoogle Scholar
• Schulz P., Chardo F., Degli Agosti R., Schaad N., Rivest R. W. Parallel nocturnal secretion of melatonin and testosterone in the plasma of normal man. J. Pineal Res. 1995; 19: 16–22
   PubMed Web of Science ®Google Scholar
• Touitou Y., Févre M., Lagoguey M., Carayon A., Bogdan A., Reinberg A., Beck H., Cesselin F., Touitou C. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J. Endocrinol. 1981; 91: 467–475
   PubMed Web of Science ®Google Scholar
• Skwarlo-Sonta K. Functional connection between the pineal gland and immune system. Acta Neurobiol. Exp. 1996; 56: 341–357
   PubMed Web of Science ®Google Scholar
• Conti A., Maestroni G. J.M. The clinical neuroimmunotherapeutic role of melatonin in oncology. J. Pineal Res. 1995; 19: 103–110
   PubMed Web of Science ®Google Scholar
• Maestroni G. J.M. Melatonin as a therapeutic agent in experimental endotoxic shock. J. Pineal Res. 1996; 20: 84–89
   PubMed Web of Science ®Google Scholar
• Brackowski R., Zubelewicz B., Romanowski W., Lissoni P., Barni S., Tancini G., Maestroni G. J.M. Preliminary study on modulation of the biological effects of tumor necrsosi factor-alpha in advanced cancer patients by the pineal hormone melatonin. J. Biol. Regul. Homeost. Agents 1994; 8: 77–80
   PubMed Web of Science ®Google Scholar
• Massion A. O., Teas J., Herbert J. R., Wertheimer M. D., Kabat-Zinn J. Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. Med. Hypotheses 1995; 44: 39–46
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging Clin. Exp. Res. 1995; 7: 340–351
   Web of Science ®Google Scholar
• Sewerynek E., Ortiz G. G., Reiter R. J., Pablos M. I., Melchiom D., Daniels W. M.U. Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol. Cell. Endocrinol. 1996; 117: 183–188
   PubMed Web of Science ®Google Scholar
• Hätönen T., Alila A., Laakso M-L. Exogenous melatonin fails to counteract the light-induced phase delay of human melatonin rhythm. Brain Res. 1996; 710: 125–130
   PubMed Web of Science ®Google Scholar
• Laakso M-L., Hätönen T., Alila A. Uncoupling of the pineal melatonin synthesis of rats from the circadian regulation. Neurosci. Lett. 1994; 179: 543
   Google Scholar
• Selmaoui B., Touitou Y. Sinusoidal 50-Hz magnetic fields depress rat pineal NAT activity and serum melatonin, role of duration and intensity of exposure. Life Sci. 1995; 57: 1351–1358
   PubMed Web of Science ®Google Scholar
• Kato M., Honma K., Shigemitsu T., Shiga Y. Circularly polarized 50-Hz magnetic fields exposure reduces pineal gland and blood melatonin concentration of Long-Evans rats. Neurosci. Lett. 1994; 166: 59–62
   PubMed Web of Science ®Google Scholar
• Duchene A. S., Lakey J. R., Repachoili M. H. IRPA/INIRC Guidelines on Protection Against Non-ionizing Radiation. Pergamon Press, Elmsford, NY 1991
   Google Scholar
• Bakos J., Nagy N., Thuróczy G., Szabó L. D. Sinusoidal 50 Hz, 500μT magnetic field has no acute effect on urinary 6-sulphatoxymelatonin in Wistar rats. Bioelectromagnetics 1995; 16: 377–380
   PubMed Web of Science ®Google Scholar
• Selmaoui B., Lambrozo J., Touitou Y. Magnetic fields and pineal function in humans: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci. 1996; 58: 1539–1549
   PubMed Web of Science ®Google Scholar
• Stieglitz A., Speigelhalter F., Klante G., Heldmayer G. Urinary 6-sulphatoxy melatonin excretion reflects pineal melatonin secretion in the Djungarian hamster (Phodopus sungoas). J. Pineal Res. 1995; 18: 69–76
   PubMed Web of Science ®Google Scholar
• Pohjanvirta R., Laitinen J., Vakkuri O., Linden J., Kokkola T., Unkila M., Tuomisto J. Mechanisms by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology 1996; 107: 85–97
   PubMed Web of Science ®Google Scholar
• Vakkuri O., Leppäluoto J., Vuolteenaho O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol. 1984; 106: 152–157
   PubMedGoogle Scholar
• Aldhous M. E., Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann. Clin. Biochem. 1988; 25: 298–303
   PubMed Web of Science ®Google Scholar
• Bartsch H., Bartsch C., Mecke D., Lippert T. H. Seasonality of pineal melatonin production in the rat: possible synchronization by the geomagnetic field. Chronobiol. Int. 1994; 11: 21–26
   PubMed Web of Science ®Google Scholar
• Kato M., Honma K., Shigemitsu T., Shiga Y. Horizontal or vertical 50 Hz, 1-μT magnetic fields have no effect on pineal gland or plasma melatonin concentration of albino rats. Neurosci. Lett. 1994; 168: 205–208
   PubMed Web of Science ®Google Scholar
• Bakos J., Nagy N., Thuróczy G., Szabó L. D. Urinary 6-sulphatoxymelatonin excretion is increased in rats after 24 hours of exposure to vertical 50 Hz, 100 μT magnetic field. Bioelectromagnetics 1997; 18: 190–192
   PubMed Web of Science ®Google Scholar
• Yellon S. M. 60-Hz magnetic field exposure effects on the melatonin rhythm and photoperiod control of reproduction. Am. J. Physiol. 1996; 270: E816–E821
   PubMed Web of Science ®Google Scholar